Cited by 120Histiocytic Disorders and TreatmentsImmunotherapy and Immune ResponsesImmune responses and vaccinations

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Langerhans cell origin and regulation

Open access
Collin, Matthew, Milne, Paul·2016·Current Opinion in Hematology

Abstract

PURPOSE OF REVIEW: This article summarizes recent research on the ontogeny of Langerhans cells and regulation of their homeostasis in quiescent and inflamed conditions. RECENT FINDINGS: Langerhans cells originate prenatally and may endure throughout life, independently of bone marrow-derived precursors. Fate-mapping experiments have recently resolved the relative contribution of primitive yolk sac and fetal liver hematopoiesis to the initial formation of Langerhans cells. In postnatal life, local self-renewal restores Langerhans cell numbers following chronic or low-grade inflammatory insults. However, severe inflammation recruits de-novo bone marrow-derived precursors in two waves; a transient population of classical monocytes followed by uncharacterized myeloid precursors that form a stable self-renewing Langerhans cell network as inflammation subsides. Human CD1c⁺ dendritic cells have Langerhans cell potential in vitro, raising the possibility that dendritic cell progenitors provide the second wave. Langerhans cell development depends upon transforming growth factor beta receptor signaling with distinct pathways active during differentiation and homeostasis. Langerhans cell survival is mediated by multiple pathways including mechanistic target of rapamycin and extracellular signal-regulated kinase signaling, mechanisms that become highly relevant in Langerhans cell neoplasia. SUMMARY: The study of Langerhans cells continues to provide novel and unexpected insights into the origin and regulation of myeloid cell populations. The melding of macrophage and dendritic cell biology, shaped by a unique habitat, is a special feature of Langerhans cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/moh.0000000000000202

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 3

  1. van Furth, 1972, Bull World Health Organ, 46, 845
  2. Merad, 2002, Nat Immunol, 31, 135
  3. Hieronymus, 2015, iol, 41, 30

Cited by

Sorted by citations

See all 120

Metadata

Authors
Collin, M., & Milne, P.
Affiliations
Newcastle University (GB)
Corresponding author
Collin, Matthew
Venue
Current Opinion in Hematology
Published
2016-01
Volume
23
Issue
1
Pages
28-35
ISSN
1065-6251 (ISSN-L)
OpenAlex
W2409593987
Cited by
120
References
65
Citations by year
2026: 8 · 2025: 10 · 2024: 10 · 2023: 8 · 2022: 12 · 2021: 16 · 2020: 14 · 2019: 13 · 2018: 12 · 2017: 10 · 2016: 6
FWCI
1.15
Type
journal article
Language
en
Open access
Locations
  • Current Opinion in Hematology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
  • Histiocytosis Association
  • Wellcome Trust
Topics
  • Health Sciences › Medicine › Hematology › Histiocytic Disorders and Treatments
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Keywords
Langerhans cells, fetal liver hematopoiesis, yolk sac hematopoiesis, self-renewal, inflammation, classical monocytes, myeloid precursors, CD1c+ dendritic cells, dendritic cell progenitors, mTOR signaling, ERK signaling, myeloid cell development
MeSH terms
Cell Self Renewal, Animals, Cell Differentiation, Fetus, Histiocytosis, Langerhans-Cell, Homeostasis, Humans, Inflammation, Langerhans Cells, Liver, Macrophages, Monocytes, Stem Cells, Yolk Sac, Cell Lineage

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review